Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nong Yang

Showing results (41-50 of 208) with videos related to

Pageof 21
Sort By:
Bioorganic Chemistry|July 4, 2021
New cytotoxic dichapetalins in the leaves of Phyllanthus acidus: Identification, quantitative analysis, and preliminary toxicity assessmentHui-Chun Geng, Hong-Tao Zhu, Wei-Nong Yang, et al.
Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu|October 6, 2005
[A study on preparation and characteristic of RuO2/TiO2 coupled photocatalyst]Bing-hua Yao, Li-ming Wang, Xiao-jiao Yu, et al.
Protein and Peptide Letters|June 1, 2018
Therapeutic Drug Monitoring of Targeted Therapy in Metastatic Renal Cell CarcinomaDehua Liao, Dangang Shangguan, Dunwu Yao, et al.
Journal of Cancer|October 22, 2019
Mast cells induce epithelial-to-mesenchymal transition and migration in non-small cell lung cancer through IL-8/Wnt/β-catenin pathwayJingjing Qu, Tianli Cheng, Li Liu, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2019
EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in patients with EGFR-mutant NSCLC and multiple brain metastasesTao Jiang, Yongchang Zhang, Xuefei Li, et al.
Journal of Cancer|July 24, 2019
Mast cells induce epithelial-to-mesenchymal transition and migration in non-small cell lung cancer through IL-8/Wnt/β-catenin pathwayJingjing Qu, Tianli Cheng, Li Liu, et al.
Oncotargets and Therapy|August 18, 2020
Comparison of Next-Generation Sequencing and Ventana Immunohistochemistry in Detecting ALK Rearrangements and Predicting the Efficacy of First-Line Crizotinib in Patients with Advanced Non-Small Cell Lung CancerLiang Zeng, Yizhi Li, Qinqin Xu, et al.
Cancer Chemotherapy and Pharmacology|July 25, 2018
Correlation of plasma erlotinib trough concentration with skin rash in Chinese NSCLC patients harboring exon 19 deletion mutationDehua Liao, Dunwu Yao, Ni Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|March 26, 2020
A novel ROS1 G2032 K missense mutation mediates lorlatinib resistance in a patient with ROS1-rearranged lung adenocarcinoma but responds to nab-paclitaxel plus pembrolizumabYuling Zhou, Wenjuan Jiang, Liang Zeng, et al.
Talanta|September 12, 2023
A microfluidic array enabling generation of identical biochemical stimulating signals to trapped biological cells for single-cell dynamicsMiao Yu, Yong-Jiang Li, Yu-Nong Yang, et al.
Pageof 21

Showing results (41-50 of 208) with videos related to

Sort By:
Pageof 21
Bioorganic Chemistry|July 4, 2021
New cytotoxic dichapetalins in the leaves of Phyllanthus acidus: Identification, quantitative analysis, and preliminary toxicity assessmentHui-Chun Geng, Hong-Tao Zhu, Wei-Nong Yang, et al.
Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu|October 6, 2005
[A study on preparation and characteristic of RuO2/TiO2 coupled photocatalyst]Bing-hua Yao, Li-ming Wang, Xiao-jiao Yu, et al.
Protein and Peptide Letters|June 1, 2018
Therapeutic Drug Monitoring of Targeted Therapy in Metastatic Renal Cell CarcinomaDehua Liao, Dangang Shangguan, Dunwu Yao, et al.
Journal of Cancer|October 22, 2019
Mast cells induce epithelial-to-mesenchymal transition and migration in non-small cell lung cancer through IL-8/Wnt/β-catenin pathwayJingjing Qu, Tianli Cheng, Li Liu, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2019
EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in patients with EGFR-mutant NSCLC and multiple brain metastasesTao Jiang, Yongchang Zhang, Xuefei Li, et al.
Journal of Cancer|July 24, 2019
Mast cells induce epithelial-to-mesenchymal transition and migration in non-small cell lung cancer through IL-8/Wnt/β-catenin pathwayJingjing Qu, Tianli Cheng, Li Liu, et al.
Oncotargets and Therapy|August 18, 2020
Comparison of Next-Generation Sequencing and Ventana Immunohistochemistry in Detecting ALK Rearrangements and Predicting the Efficacy of First-Line Crizotinib in Patients with Advanced Non-Small Cell Lung CancerLiang Zeng, Yizhi Li, Qinqin Xu, et al.
Cancer Chemotherapy and Pharmacology|July 25, 2018
Correlation of plasma erlotinib trough concentration with skin rash in Chinese NSCLC patients harboring exon 19 deletion mutationDehua Liao, Dunwu Yao, Ni Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|March 26, 2020
A novel ROS1 G2032 K missense mutation mediates lorlatinib resistance in a patient with ROS1-rearranged lung adenocarcinoma but responds to nab-paclitaxel plus pembrolizumabYuling Zhou, Wenjuan Jiang, Liang Zeng, et al.
Talanta|September 12, 2023
A microfluidic array enabling generation of identical biochemical stimulating signals to trapped biological cells for single-cell dynamicsMiao Yu, Yong-Jiang Li, Yu-Nong Yang, et al.
Pageof 21